Early-life events may trigger biochemical pathways for Alzheimer’s disease: the “LEARn” model

被引:0
|
作者
Debomoy K. Lahiri
Nasser H. Zawia
Nigel H. Greig
Kumar Sambamurti
Bryan Maloney
机构
[1] Indiana University School of Medicine,Department of Psychiatry, Institute of Psychiatric Research
[2] University of Rhode Island,Department of Biomedical and Pharmaceutical Sciences
[3] National Institute of Aging,Laboratory of Neurosciences, Intramural Research Program
[4] NIH,Department of Physiology and Neuroscience
[5] Medical University of South Carolina,undefined
来源
Biogerontology | 2008年 / 9卷
关键词
Latency; Gene regulation; Methylation; Epigenetic; Amyloid; Lead; Pb;
D O I
暂无
中图分类号
学科分类号
摘要
Alzheimer’s disease (AD), the most common form of dementia among the elderly, manifests mostly late in adult life. However, it is presently unclear when the disease process starts and how long the pathobiochemical processes take to develop. Our goal is to address the timing and nature of triggers that lead to AD. To explain the etiology of AD, we have recently proposed a “Latent Early-life Associated Regulation” (LEARn) model, which postulates a latent expression of specific genes triggered at the developmental stage. This model integrates both the neuropathological features (e.g., amyloid-loaded plaques and tau-laden tangles) and environmental factors (e.g., diet, metal exposure, and hormones) associated with the disease. Environmental agents perturb gene regulation in a long-term fashion, beginning at early developmental stages, but these perturbations do not have pathological results until significantly later in life. The LEARn model operates through the regulatory region (promoter) of the gene and by affecting the methylation status within the promoter of specific genes.
引用
收藏
相关论文
共 50 条
  • [21] Emotional expression, life events and Alzheimer's disease
    Haigh, Anne-Marie F.
    Wilcock, Gordon K.
    King, Elizabeth M. F. O.
    Yerrell, Paul
    INTERNATIONAL PSYCHOGERIATRICS, 2011, 23 : S13 - S14
  • [22] Metabolite-initiated protein misfolding may trigger Alzheimer's disease
    Zhang, QH
    Powers, ET
    Nieva, J
    Huff, ME
    Dendle, MA
    Bieschke, J
    Glabe, CG
    Eschenmoser, A
    Wentworth, P
    Lerner, RA
    Kelly, JW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (14) : 4752 - 4757
  • [23] Changes in lipid membranes may trigger amyloid toxicity in Alzheimer's disease
    Drolle, Elizabeth
    Negoda, Alexander
    Hammond, Keely
    Pavlov, Evgeny
    Leonenko, Zoya
    PLOS ONE, 2017, 12 (08):
  • [24] Changes in Lipid Membrane May Trigger Amyloid Toxicity in Alzheimer's Disease
    Drolle, Elizabeth
    Turnbull, Stephen
    Mei, Nanqin
    Filice, Carina
    Lee, Brenda Y.
    Robinson, Morgan
    Pavlov, Evgeny
    Finot, Eric
    Leonenko, Zoya
    BIOPHYSICAL JOURNAL, 2019, 116 (03) : 427A - 427A
  • [25] Early-life inflammation pathways trigger a cascade leading to development of atherosclerotic plaque through the "butterfly effect" - An hypothesis
    Kowara, M.
    Kasarello, K.
    Czarzasta, K.
    Opolski, G.
    Cudnoch-Jedrzejewska, A.
    MEDICAL HYPOTHESES, 2019, 122 : 106 - 110
  • [26] Early-Life Exposure to Lead (Pb) Alters the Expression of microRNA that Target Proteins Associated with Alzheimer's Disease
    Masoud, Anwar M.
    Bihaqi, Syed W.
    Machan, Jason T.
    Zawia, Nasser H.
    Renehan, William E.
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 51 (04) : 1257 - 1264
  • [27] Early life circumstances and late life Alzheimer's disease
    Breteler, MMB
    EPIDEMIOLOGY, 2001, 12 (04) : 378 - 379
  • [28] Biochemical diagnostic markers to detect early Alzheimer's disease
    Lannfelt, L
    NEUROBIOLOGY OF AGING, 1998, 19 (02) : 165 - 167
  • [29] Association of Early-Life Cognitive Enrichment With Alzheimer Disease Pathological Changes and Cognitive Decline
    Oveisgharan, Shahram
    Wilson, Robert S.
    Yu, Lei
    Schneider, Julie A.
    Bennett, David A.
    JAMA NEUROLOGY, 2020, 77 (10) : 1217 - 1224
  • [30] Synaptobrevin may be an early marker for Alzheimer's disease (AD).
    Bi, H
    Sze, CI
    Kleinschmidt-DeMasters, BK
    Filley, CM
    Martin, LJ
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1999, 58 (05): : 532 - 532